CoagulationDisorders near Elmhurst, NY

Biography: Dr. Jini Hyun is an Assistant Professor of Clinical Medicine at Weill Cornell Medicine and Attending Physician at New York-Presbyterian Queens (NYPQ). After obtaining her Masters of Science in Pharmacology and Pharmacognosy at the Seoul National University in 2001, Dr. Hyun performed research at the University of Illinois at Chicago before obtaining her medical degree from St. George's University in 2013.She was a rotating resident at the National Heart, Lung and Blood Institute in 2015. In 2017, Dr. Hyun completed an internal medicine residency at NewYork-Presbyterian Queens where she also served as Chief Resident. Following residency, Dr. Hyun completed her hematology and medical oncology fellowship training at SUNY Downstate Medical Center where she held the title of Chief Fellow. Dr. Hyun is part of the Hematology and Medical Oncology team at NYPQ and is accepting new patients.

Care Philosophy: Our medical center provides an extraordinary opportunity to work with clinicians and scientists with expertise in all facets of HIV/AIDS and clotting disorders associated with small blood vessel injury such as TTP and aHUS. Working with them in the diagnosis and treatment of these diseases for over 25 years, I have developed a strong interest in HIV-related hematologic disorders as well as osteoporosis and other metabolic complications arising during antiretroviral therapy for HIV.

Biography: Michal Bar-Natan, MD, is Interim Assistant Professor of Medicine and a member of the Leukemia Program at Weill Cornell Medicine and NewYork-Presbyterian Hospital in New York City.Dr. Bar-Natan graduated cum laude from the Sackler School of Medicine. She completed her Internal Medicine Residency at Sheba Medical Center and her Fellowship in Hematology and Medical Oncology at NYU Langone Health.In addition to her clinical fellowship training, Dr. Bar-Natan completed a research fellowship at Dana Farber Cancer Institute and Brigham and Women's Hospital (Harvard Medical School) with a focus on the role that signal transducer and activator of transcription (STAT) proteins play in the development and treatment of myeloproliferative neoplasms (MPNs) and leukemias.Prior to this position Dr. Bar-Natan served as Associate Professor of Medicine at the Icahn School of Medicine at Mt. Sinai, an Attending Physician with the Center of Excellence for Blood Cancers and Myeloid Disorders, and as the leader of the Acute Lymphoblastic Leukemia programat the Mt. Sinai Tisch Cancer Institute.Dr. Bar-Natan's focus is on translational research in malignant hematology, particularly myeloid malignancies and acute lymphoblastic leukemia, and the development of investigator-initiated clinical trials for patients with these conditions. She leads early phase clinical trials implementing new therapeutic approaches, such as immunotherapies and combination therapies, and serves as the PI and co-investigator on many clinical trials for acute leukemias and myeloproliferative neoplasms.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person.